Transcriptional Induction of Matrix Metalloproteinase-13 (Collagenase-3) by 1α,25-Dihydroxyvitamin D3 in Mouse Osteoblastic MC3T3-E1 Cells
Open Access
- 1 February 2001
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 16 (2) , 221-230
- https://doi.org/10.1359/jbmr.2001.16.2.221
Abstract
The removal of unmineralized matrix from the bone surface is essential for the initiation of osteoclastic bone resorption because osteoclasts cannot attach to the unmineralized osteoid. Matrix metalloproteinases (MMPs) are known to digest bone matrix. We recently reported that among the MMPs expressed in mouse osteoblastic cells, MMP-13 (collagenase-3) was the one most predominantly up-regulated by bone resorbing factors including 1alpha,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3]. In this study, we examined the mechanism of regulation of MMP-13 expression by 1alpha,25(OH)2D3 in mouse osteoblastic MC3T3-E1 cells. 1Alpha,25(OH)2D3 increased steady-state messenger RNA (mRNA) and protein levels of MMP-13. De novo protein synthesis was essential for the induction because cycloheximide (CHX) decreased the effect of 1alpha,25(OH)2D3 on the MMP-13 mRNA level. 1Alpha,25(OH)2D3 did not alter the decay of MMP-13 mRNA in transcriptionally arrested MC3T3-E1 cells; however, it increased the MMP-13 heterogeneous nuclear RNA (hnRNA) level and MMP-13 transcriptional rate. The binding activity of nuclear extracts to the AP-1 binding site, but not to the Cbfa1 binding site, in the MMP-13 promoter region was up-regulated by 1alpha,25(OH)2D3, suggesting the mediation of AP-1 in this transcriptional induction. To determine the contribution of MMPs to bone resorption by 1alpha,25(OH)2D3, the inhibitory effect of BB94, an MMP inhibitor, on resorbed pit formation by mouse crude osteoclastic cells was examined on either an uncoated or collagen-coated dentine slice. BB94 did not prevent resorbed pit formation on uncoated dentine whereas it did on collagen-coated dentine. We therefore propose that the transcriptional induction of MMP-13 in osteoblastic cells may contribute to the degradation of unmineralized matrix on the bone surface as an early step of bone resorption by 1alpha,25(OH)2D3.Keywords
This publication has 46 references indexed in Scilit:
- Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cellsJournal of Cellular Physiology, 2000
- The Migration of Purified Osteoclasts Through Collagen Is Inhibited by Matrix Metalloproteinase InhibitorsJournal of Bone and Mineral Research, 1998
- Regulation of rat interstitial collagenase gene expression in growth cartilage and chondrocytes by vitamin D3, interleukin-1β, and okadaic acidJournal of Cellular Biochemistry, 1996
- Osteoclast molecular phenotyping by random cDNA sequencingBone, 1995
- Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: evidence for a plasminogen-plasmin-metalloproteinase activation cascadeBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1989
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- Degradation of type I collagen films by mouse osteoblasts is stimulated by 1,25 dihydroxyvitamin D3 and inhibited by human recombinant TIMP (tissue inhibitor of metalloproteinases)Biochemical and Biophysical Research Communications, 1987
- In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria.The Journal of cell biology, 1983
- Receptors for 1,25(OH)2‐vitamin D3 enriched in cloned osteoblast‐like rat osteogenic sarcoma cellsFEBS Letters, 1980
- The effects of vitamin D analogues on bone resorptionCalcified Tissue International, 1974